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ABSTRACT: Chronic wasting disease (CWD) is a highly
infectious prion disease of cervids. Accumulation of prions,
the disease-specific structural conformers of the cellular prion
protein (PrPC), in the central nervous system, is the key
pathological event of the disorder. The analysis of cervid PrPC
sequences revealed the existence of polymorphism at position
226, in which deer PrP contains glutamine (Q), whereas elk
PrP contains glutamate (E). The effects of this polymorphism
on CWD are still unknown. We determined the high-
resolution nuclear magnetic resonance structure of the mule
deer prion protein that was compared to previously published PrP structures of elk and white-tailed deer. We found that the
polymorphism Q226E could influence the long-range intramolecular interactions and packing of the β2−α2 loop and the C-
terminus of the α3 helix of cervid PrP structures. This solvent-accessible epitope is believed to be involved in prion conversion.
Additional differences were observed at the beginning of the well-defined C-terminus domain, in the α2−α3 region, and in its
interactions with the α1 helix. Here, we highlight the importance of the PrP structure in prion susceptibility and how single
amino acid differences might influence the overall protein folding.
■ INTRODUCTION
Chronic wasting disease (CWD) is an infectious prion disease
of free-ranging cervids. It has been reported in both captive
and wild cervid species, including elk (Cervus canadensis), mule
deer (Odocoileus hemionus), white-tailed deer (Odocoileus
virginianus), red deer (Cervus elaphus), reindeer (Rangifer
tarandus), and moose (Alces alces).1−7 The disease has now
been reported in 26 states of the United States, three provinces
of Canada, South Korea, Norway, Finland, and Sweden.7−12
Prion diseases, also known as transmissible spongiform
encephalopathies (TSEs), are rapid, progressive, and devastat-
ing neurodegenerative disorders, caused by misfolding events
of the main α-helical cellular prion protein (PrPC) to a β-sheet-
enriched, partially protease-resistant, and infectious isoform
(PrPSc or prion).13,14 Although there is a lack of high-
resolution three-dimensional (3D) structural data for PrPSc
(mostly because of its insolubility and propensity to
aggregate),15 the PrPC structure has been solved by solution-
state nuclear magnetic resonance (NMR) and crystallographic
methods. PrPC consists of a highly flexible N-terminal segment
(residues 23−124) and a folded C-terminus domain (residues
125−231).15,16 The C-terminus domain contains three α-
helices, spanning residues 144−154 (α1), 173−194 (α2), and
200−228 (α3), and two short antiparallel β-strands comprising
residues 128−131 (β1) and 161−164 (β2). The PrP expressed
by mammalian species exhibits a similar fold, with the local
sequence and structure variations most prominently localized
at the interface of the β2−α2 loop and in the C-terminus part
of the α3 helix.17
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Among the mammalian prion diseases, CWD is the most
infectious form. Free-ranging cervids are at the highest risk of
exposure to CWD prions through direct horizontal trans-
mission via infectious agents such as saliva, urine, and feces or
through an indirect transmission occurring by environmental
exposure to contaminated and infectious material.18,19 The
ability of PrPSc to selectively infect some mammalian species
rather than others is known as species barriers.20,21 The
primary structural identity between PrPC and PrPSc facilitates
prion transmission, thus influencing resistance or susceptibility
to prion conversion.22,23 Naturally occurring PrP poly-
morphisms that alter prion disease susceptibility have been
documented in many species.24 In humans, the polymorphic
residue at codon 129 (M129V) influences the susceptibility to
prion diseases,25 where the presence of valine induces the
formation of unstable intermolecular β-sheets, conflicting with
the spatially adjacent residues.26,27
Polymorphisms and few allelic variations in the well-
conserved Prnp gene within the family Cervidae may influence
the different susceptibility of CWD progression and PrPSc
infection.28,29 Polymorphisms M132L and S225F in elk and
mule deer are related to increased resistance to CWD.28,30,31
Additionally, a single difference in primary structure exists
between elk and deer PrP; elk PrP contains glutamic acid (E)
at position 226, whereas deer PrP contains glutamine (Q) at
this position28,32 (Figure 1). Polymorphism Q226E is related
to the identification of biologically distinct prion strains on the
basis of different disease progressions in deer and elk.33,34
Recently, it was shown that amino acid variation at residue 226
of deer and elk PrP controls the disease onset and
conformational features of the resulting prions, thus confirming
the presence of different cervid strains.35 Moreover, replace-
ment of the coding sequence of mouse PrP with the deer or elk
sequence renders the mice highly susceptible to CWD prions.
Therefore, the analysis of structural features of PrP is of
outstanding importance for a better understanding of the
pathogenesis and transmission of TSEs.
In the current study, we have determined a high-resolution
structure of the truncated recombinant mule deer PrP (from
residues 94 to 233, hereafter indicated as mdPrP) with the use
Figure 1. Sequence alignment of PrPs of cervid subspecies with confirmed CWD. Amino acid variants are marked with orange color. Residue
numbering is based on the mdPrP amino acid sequence. Secondary structural elements are summarized based on the mdPrP structural model
presented in this article, with the α-helices of mdPrP denoted by green rectangles, 310-helices by light green rectangles, β-strands by magenta
arrows, flexible N-terminal tail by a curved line, and linkers between the secondary structure elements by straight lines, both lines colored
champagne pink.
Figure 2. 15N-HSQC spectrum of mdPrP with the amino acid assignment. Cross-peaks of the side chains of Asn, Gln, and Trp are not marked.
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of NMR spectroscopy. A comparison to previously determined
PrP structures from the white-tailed deer and Rocky Mountain
elk36,37 provides insights that may contribute to our under-
standing of how the single polymorphism Q226E between deer
and elk can alter the structure and help to explain the
substantial differences in biochemical properties, pathogenesis,
and formation of different strains of CWD prions among
cervids.38 We hypothesized that the presence of polymorphism
Q226E, as the most critical for CWD among the six identified
differences in amino acid sequences, could influence the long-
range intramolecular interactions including the packing of the
β2−α2 loop and the C-terminus of the α3 helix. This solvent-
accessible epitope has been studied greatly in view of its role in
prion conversion.39,40 Additionally, the changes from the
neutral to negatively charged side chain at position 226 will
influence the electrostatic surface potential in this region,
which is of great relevance for the intermolecular interactions
between PrPC and PrPSc among cervids.
■ RESULTS AND DISCUSSION
Amino Acid Alignment and mdPrP Construct. The
amino acid sequences of PrPs from various cervid subspecies
related to CWD are highly evolutionary-conserved. The
alignment of amino acid sequences of mdPrP, white-tailed
deer (wtdPrP), elk (ePrP), red deer PrP (reddPrP), American
moose PrP (amPrP), Eurasian moose PrP (emPrP), and
reindeer PrP (rdPrP) showed differences in the amino acid
residues at positions 109, 123, 138, 176, 209, and 226 (Figure
1; numbering is based on the amino acid sequence of the
mdPrP construct used herein for structure determination). A
simple perusal of the differences shows that the three of them
are positioned within the well-defined secondary structural
elements. Truncated recombinant mdPrP from residues 94 to
233 with serine at position 138 and glutamine at position 226
was used for structural characterization and comparison with
previously resolved wtdPrP and ePrP structures.
Resonance Assignment and Structure Calculation.
The 15N-heteronuclear single quantum coherence (HSQC)
spectrum of 13C, 15N doubly labeled mdPrP presents a
favorable dispersion of cross-peaks, indicating a high potential
for in-depth structural determination (Figure 2). Standard two-
dimensional and 3D NMR experiments were used for the
assignment of backbone and side-chain resonances of mdPrP.
In short, the sequence-specific assignment of the backbone 1H,
15N, 13Cα,
13Cβ, and
13CO resonances for mdPrP was obtained
using the 15N-HSQC spectrum and triple-resonance HNCO,
HN(CO)CA, HNCA, CBCA(CO)NH, and HNCACB experi-
ments.41 The 1H and 13C resonances of aliphatic and aromatic
side chains were assigned using 13C-HSQC in combination
with HAHB(CO)NH, CC(CO)NH, (H)CCH- total correla-
tion spectroscopy (TOCSY), and 13C-edited nuclear Over-
hauser enhancement spectroscopy (NOESY)-HSQC experi-
ments.42 NOE contacts were determined in 3D 15N and 13C-
edited NOESY-HSQC experiments. The overall completeness
of chemical shift assignment was 99.1%. Noteworthily, the
side-chain resonances including CHε of His
99, His114, and
Tyr152 and CHζ of Phe
178 and Phe201 could not be
unambiguously assigned; however, this agrees very well with
the final structure and properties of the studied protein. We
have considered the use of residual dipolar couplings for
structure improvement, especially interhelical orientations.
However, the use of aligning media was showed to induce
sample precipitation of PrPs.
The high-resolution structure of mdPrP was calculated using
545 intraresidual, 618 sequential, 482 medium-range, and 559
long-range distance restraints complemented with 168 back-
bone torsion angle restraints (Table 1). The calculated
structure of mdPrP (PDB ID: 6FNV) is composed of two
distinct domains. The highly disordered N-terminal domain
consists of residues from Gly94 to Gly122, whereas the well-
defined C-terminus domain is composed of residues from
Ala123 to Ala233 and exhibits a backbone root-mean-square
deviation (rmsd) of 0.42 Å (Figure 3A and Table 1).
The C-terminus domain of mdPrP is characterized by a
compact set of three α-helices and a short antiparallel β-sheet.
The α1 helix is composed of residues from Asp147 to Asn156
and is followed by the 310-helix turn from Met
157 to Arg159. The
geometry of α1 helix is classified as kinked according to the
HELANAL web server.46,47 The α2 and α3 helices are longer
than the α1 helix and are composed of residues from Gln175 to
Lys197 and from Glu203 to Gln230, respectively. The geometries
of α2 and α3 helices are linear and of curved type, respectively.
The helices α2 and α3 form a twisted V-shaped skeleton that
serves as a platform for anchoring the α1 helix and β-sheet.
The antiparallel β-sheet is formed at the beginning of the C-
terminus domain and consists of two β strands, β1 and β2, that
are composed of residues from Met132 to Leu133 and from
Tyr165 to Tyr166, respectively. The structure of mdPrP is
Table 1. NMR Restraints and Structural Statistics for an
Ensemble of 20 Lowest Energy Structures of mdPrP
NOE upper distance limitsa
total 2204
intraresidue (|i − j| = 0) 545
sequential (|i − j| = 1) 618
medium-range (1 < |i − j| < 5) 482
long-range (|i − j| ≥ 5) 559
torsion angle restraintsa
backbone (φ/ψ) 168
rmsd to the mean coordinates (Å)
ordered backbone atoms (123−231) 0.42 ± 0.08
ordered heavy atoms (123−231) 0.78 ± 0.09
Ramachandran plot (123−231)b
residues in most favored regions (%) 95.0
residues in additional allowed regions (%) 5.0
structure Z scoresb
first generation packing quality 0.763 ± 0.513
second generation packing quality 5.102 ± 1.464
Ramachandran plot appearance −0.453 ± 0.282
chi-1/chi-2 rotamer normality −3.717 ± 0.483
backbone conformation −0.541 ± 0.234
rms Z scoresb
bond lengths 1.143 ± 0.003
bond angles 0.465 ± 0.011
omega angle restraints 0.481 ± 0.032
side-chain planarity 0.358 ± 0.029
improper dihedral distribution 0.571 ± 0.017
inside/outside distribution 1.030 ± 0.011
aNone of the 20 structures exhibits distance violations over 0.2 Å and
torsion angle violation over 5°. bensemble of structures was analyzed
by PROCHECK-NMR43 and WhatIF programs incorporated in
ICING structure evaluation package44 and PSVS.45
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stabilized by a disulfide bond between Cys182 and Cys217 that is
located in the middle of α2 and α3 helices.
Unique Structural Features of the mdPrP Protein. We
observed the structuring of the region at the beginning of the
C-terminus domain of mdPrP. This region consists of nine
residues from Ala123 to Tyr131 and adopts a well-defined
structure with the backbone rmsd of 0.22 Å (Figure 3B). It is
characterized by an α-helical turn and a γ-turn that are
stabilized by three hydrogen bonds (Figure 3C). The carbonyl
group of Val125 is involved in a bifurcated hydrogen bond with
the amide protons of Leu128 and Gly129 in the α-helical turn. In
addition, a hydrogen bond is formed between the carbonyl
group of Leu128 and the amide proton of Gly130 in the γ-turn.
An hydrophobic pocket in this region is formed by Val125,
Leu128, and Tyr131 (Figure 3B,C).
Additionally, the β2−α2 loop of the mdPrP structure is well
defined with one turn of 310-helix from the residues Val
169 to
Gln171 (Figure 3D) held together by the Gln171HN−Pro168O
and Tyr172HN−Val169O hydrogen bonds (Figure 3E). The
β2−α2 loop is further stabilized by hydrophobic and aromatic
interactions with the nearby amino acid residues at the C-
terminus of the α3 helix. The hydrophobic pocket defined by
the β2−α2 loop and the C-terminus of the α3 helix is
composed of residues Tyr166, Val169, Tyr172, Phe178, Tyr221, and
Tyr228 (Figure 3D).
The above structuring of the region before the well-defined
C-terminus domain and the β2−α2 loop is supported further
with the study of backbone dynamics. We analyzed 118
resolved amide resonances of mdPrP on a fast (picoseconds to
nanoseconds) timescale with the use of 15N relaxation time
measurements at two magnetic fields (14.1 and 18.8 T). The
resulting 15N longitudinal (R1), transverse (R2), and rotating
frame (R1ρ) relaxation rates combined with {
1H}−15N
heteronuclear NOE (hNOE) conform to the flexible N-
terminal tail and a well-structured C-terminus domain of the
mdPrP structure (Figure 4).
Furthermore, 15N relaxation data indicate structuring for
residues from Ala123 to Tyr131 at the beginning of the C-
terminus domain and for the β2−α2 loop. On the other hand,
15N relaxation data show an increased mobility for residues
from Lys197 to Phe201 that connect α2 and α3 helices and for
residues from Tyr229 to Ala233 at the C-terminus of the mdPrP
structure. However, the relative lower values of R2 and R1ρ
relaxation rates for residues around Ile142 and Gln189 are not
indicative of a well-defined secondary structure and suggest
more complex dynamics coupled to their intricate tertiary
interaction. Few amino acid residues could not be analyzed
because of the cross-peak overlap (for details, see Methods).
Comparison of Structures of mdPrP and Other
Cervids. Cervid prion proteins exhibit a well-conserved
Figure 3. Structure of mdPrP. (A) Ensemble of 20 lowest energy structures of mdPrP (residues form Ala123 to Ala233). α-Helices and 310-helix are
colored green, β-sheets are colored magenta, and loops are colored champagne pink. (B) Well-defined region between residues Ala123 and Tyr131.
(C) Residues from Ala123 to Tyr131 involved in the formation of α-helical turn (Val125−Leu128) and γ-turn (Leu128−Gly130). (D) Hydrophobic
pocket in the proximity of the β2−α2 loop and the C-terminus of the α3 helix. (E) 310-Helix from residues Pro168 to Tyr172 inside the β2−α2 loop.
Residues are presented as sticks in champagne pink and the hydrogen bonds in panels (C,E) are shown as dashed lines in cyan.
Figure 4. 15N amide backbone relaxation rates and hNOE of mdPrP.
(A) 15N longitudinal (R1 = 1/T1), (B) transverse (R2 = 1/T2), (C)
spin−lattice relaxation rates in the rotation frame (R1ρ = 1/T1ρ), and
(D) hNOE at 298 K at a magnetic field of 14.1 (magenta) and 18.8 T
(blue). A schematic presentation of the secondary structure elements
of mdPrP is at the top of the figure. For clarity, error bars are not
shown here as they are within the size of the data points in the above
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amino acid sequence, which may suggest similarity of their 3D
structures. We compared our mdPrP structure with the
structures of previously determined PrPs from white-tailed
deer and Rocky mountain elk and observed several differences.
For easier comparison of cervids’ PrP structures, we unified the
residue numbering based on the mdPrP amino acid sequence.
Here, we have to mention that the wtdPrP structure was
determined in complex with an antibody fragment POM1 at
pH 6.8; however, the PDB entry for wtdPrP includes residues
from 128 to 228 (PDB ID: 4YXH).36 The ePrP structure
consists of residues from 124 to 234 (PDB ID: 1XYW) and
was determined at pH 4.5.37 We used pH of 5.5 for structure
determination because the lower pH prevents aggregation and
enables longevity of the prion protein samples that is necessary
for structure determination by NMR spectroscopy. Addition-
ally, it has been suggested that misfolding of PrPs in prion
disease occurs in endosomes that exhibit a low pH (pH ≈ 5).48
In general, the fold of mdPrP is grossly similar to wtdPrP and
ePrP structures (Figure 5A), even though the structures were
determined under different sample conditions.
We compared the chemical shifts (δ) of amide proton (HN),
Cα, and Cβ atoms of amino acids from 124 to 233 between the
mdPrP and ePrP structures determined by NMR spectroscopy
(Figure S2). The chemical shifts of HN, Cα, and Cβ atoms of
mdPrP and ePrP showed good agreement along the sequence.
Slight, if not negligible, differences have been observed for
δ(HN) and δ(Cα) for the amino acid residues in the α2−α3
loop, which could indicate different long-range interactions
among amino acids in this region. The calculated rmsd for the
protein backbone of the three compared structures (residues
128−228) is 1.2 Å. The local backbone rmsd values per residue
are in good agreement with the observed differences among
the examined structures (Table S1, Figures 5 and 6). The main
differences in backbone rmsd values between the mdPrP and
ePrP structures have been detected at the N-terminal of the α1
helix and at the α2−α3 loop (Figure 6).
However, despite a very high level of numerical similarity,
structural differences are observed at the beginning of the C-
terminus domains, β2−α2 loops and their interactions with α3
Figure 5. Comparison of mdPrP, wtdPrP, and ePrP structures. (A) Superposition of well-defined C-terminus domains from amino acids Ala123−
Ala233 of mdPrP (green), wtdPrP (orange), and ePrP (magenta). The selected residues are presented as ball-and-stick and colored in champagne
pink with marked heteroatoms. (B) Structural diversity at the end of the α3 helix and the β2−α2 loop. (C) Spatial orientation of residues in the
proximity of the α2−α3 loop with marked distances. Selected distances among residues are indicated with dashed lines and small letters (see Table
2 for distance information). (D) Structural differences in orientations at the α1 helix with respect to the α2−α3 V-shaped skeleton.
Figure 6. Local rmsd values for backbone atoms per residue (from 128 to 228) of mdPrP (green) and ePrP (magenta) with respect to the wtdPrP
structure that was determined by X-ray. Standard deviations are reported for the ensemble of 20 lowest energy structures of mdPrP and ePrP.
ACS Omega Article
DOI: 10.1021/acsomega.9b02824
ACS Omega 2019, 4, 19913−19924
19917
helices, at the beginning of α1 helices and their interactions
with α2 and α3 helices, and α2−α3 loops (Figures 5 and S3).
Residues from Val124 to Gly130 in ePrP exhibit an extended
backbone conformation. Similarly, the residues from Leu128 to
Gly130 in the wtdPrP structure have no observed structuring.
Both regions of ePrP and wtdPrP structures exhibit no
hydrogen bonds in contrast to mdPrP, where we observed
three hydrogen bonds (Figures 3C, 5A and S3). No
hydrophobic pocket was observed in this region of ePrP or
wtdPrP structures, whereas mdPrP exhibits a well-defined
hydrophobic pocket composed by the residues Val125, Leu128,
Tyr131, and Ile185. The backbone structures of the three
proteins exhibit similar conformations after the residue Gly130.
Interestingly, within the examined structures, Tyr131 exhibits a
diverse side-chain orientation and distinct stacking with Tyr166
and Ile185. The relative position of Tyr131 side chain and its
interactions with the residues in proximity might have an
impact on the formation of the α-helical turn and γ-turn in
mdPrP in contrast to wtdPrP and ePrP. Solvent accessibility
analysis with the GETAREA program49,50 showed that the
Tyr131 residue is protected from exchange with solvents in all
three structures (Figure S4). However, the distance between
Tyr131 and Ile185 in the α2 helix is 2 times longer in mdPrP and
ePrP structures in comparison to the wtdPrP structure (Table
S2). In contrast, the distance between Leu128 and Ile185 is
shorter in the mdPrP structure with respect to the distances in
ePrP and wtdPrP structures (Table S2). These observations
indicate differences in interactions between the β1−α1−β2
and α2−α3 subdomains of the compared structures. It was
previously proposed that different side-chain orientations of
Tyr131 play an important role in the interactions between these
subdomains and furthermore could also affect the flexibility of
the β2−α2 loop region.36,55 In this way, the region from the
residues Ala123 to Tyr131 could additionally stabilize the mdPrP
structure through its interactions with the antiparallel β-sheet
and α2 helix and in this way prevent PrPC-to-PrPSc conversion.
The β2−α2 loop of mdPrP comprising residues 168−178 is
well-defined, composed of 310-helix, and stabilized with
aromatic and hydrophobic interactions with the nearby
residues. The backbone orientations of β2−α2 loops of the
three examined structures are similar, whereas small differences
are notable in the side-chain orientations of Val169 and Asp170
(Figure 5B). Moreover, different orientations of glutamine and
asparagine side chains in the β2−α2 loops (residues Gln171,
Asn173, Asn174, and Asn176) are observed and might be related
to the long-range interactions and orientations of the aromatic
moiety of Tyr131 in the three compared structures (Figure S3).
The structural features of β2−α2 loop have been extensively
discussed in the literature.22,56−60 The presence of Asn/Gln
residues in the β2−α2 loop can be a strong determinant for
prion conversion that overrides the differences in the sequence
and has influence on the appearance of prions according to the
zipper model between the cervid and human PrP.22 Moreover,
insertion of additional Gln residues into the β2−α2 loop of
mouse PrP promotes prion protein conversion,61−63 whereas
several substitutions (at positions 169, 171, 173, and 177;
residues numbering based on the mdPrP sequence) in the
β2−α2 loop of PrPC are believed to prevent the spontaneous
prion formation by influencing the structural stability of the
β2−α2 loop.56−59,64
Additionally, the structures and interactions of side chains in
the β2−α2 loops are influenced by the orientations of side
chains in the C-terminus of the α3 helix including the residue
at position 226. The α3 helix of wtdPrP is shorter and ends
with Ser225, possibly because of the shorter amino acid
sequence36 with respect to the mdPrP structure. The C-
terminus of ePrP protein is unstructured after Tyr228 (Figure
5B). Tyr228 and Tyr229 have different side-chain orientations in
mdPrP in comparison to the ePrP structure, as a result of their
distinct relative orientation, that lead to hydrophobic
interactions with the residues Val169, Asp170, and Ser225 and
additionally stabilize the end of the C-terminus part in mdPrP
(Figure 5B and Table S2). Tyr228 of the wtdPrP structure is
involved in stacking interactions with Asp170 in the β2−α2
loop. However, the interactions between the residues at the
end of the α3 helix and Gln226 are not observed in wtdPrP,
resulting in higher solvent accessibility of Ser225 and Gln226 in
comparison to mdPrP and ePrP (Figures 5B and S3).
Importantly, beside the polymorphism Q226E, mule deer
exhibits serine-to-asparagine polymorphism at position 138,
which is processed as a pseudogene,69,70 and serine-to-
phenylalanine polymorphism at codon 225.30 Allele Phe225 in
mule deer could contribute to CWD resistance in view of the
reported prolonged incubation period with respect to the
Ser225 mule deer homozygote.30 Interestingly, it has been
shown that polymorphisms at residues 225 and 226 affect the
interactions between the β2−α2 loop and α3 helix and
therefore prion propagation within deer and elk.40,71 Our
results showed that Ser225 is protected from solvents as it is
involved in the interaction with Tyr228 in mdPrP. Additionally,
Tyr228 in mdPrP is protected from solvents by the stacking
interaction with Val169. These data contribute to the under-
standing at the molecular level and are in agreement with the
structural and molecular dynamics studies of inter- and
intraspecies PrP transmission related to cervids that pointed
out a critical role of residues 225 and 226 in PrPC-to-PrPSc
conversion and strain propagation.40
In the three structures, α2 and α3 helices form a V-shaped
skeleton that slightly differs in the spatial orientation of the
helices. The interhelical angle between the α2 and α3 helices
of mdPrP is 44.5°, whereas its value in wtdPrP and ePrP is 49.8
and 52.2°, respectively. The hydrophobic and aromatic
residues of α2 and α3 helices have preserved architectures
that are stabilized by a disulfide bond in the three structures.
However, significant differences are observed for the side-chain
orientations of His190 and Thr194 in the α2 helix and Ile206,
Met209, and Glu210 in the α3 helix (Figures 5C and S1). These
residues are spatially close to the loop that connects α2 and α3
helices. Surprisingly, the α2−α3 loop of mdPrP exhibits a
unique backbone conformation with different orientations of
the side chains of Glu199, Asn200, and Phe201 with respect to
wtdPrP and ePrP. However, the hydrophobic interactions of
Phe201 and Tyr160 are preserved in the three structures. Major
differences are observed for distances Tyr160Cα−Val201Cβ and
Glu199Cβ−Phe201Cζ that are up to 2 Å longer in mdPrP with
respect to wtdPrP and ePrP (Table 2). The opposite is
observed for distances Thr194Cγ2−Asn200Cβ, Asn200Cβ−
Phe201Cζ, and Ile
206Cγ2−Met209Cγ that are shorter in mdPrP
with respect to the other two cervid structures (Figure 5C and
Table 2). The residue Glu199 is more exposed to the solvents,
whereas residue Asn200 is less solvent-exposed in mdPrP in
comparison to wtdPrP and ePrP (Figure 7). Different side-
chain orientations in the α2−α3 loop could influence the
interactions of residues in helices that are spatially close to this
region. In early events of oligomerization, it is believed that the
α1 helix moves away from the α2−α3 V-shaped skeleton. This
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is responsible for the increased local structural dynamics that is
reflected in greater exposure of the amide hydrogen atoms in
the α1 helix of mouse PrP.65−68 Importantly, the stabilization
of interactions or covalent linkage by a disulfide bond between
the subdomains β1−α1−β2 and α2−α3 is supposed to prevent
the oligomerization.65
Structure variations were also observed in the orientations of
the three helices and at the end of the α1 helix and its
interactions with the α2−α3 loop. The aromatic interactions
between Tyr148 and Tyr152 differ among the three structures
(Figure 5D). Furthermore, 2 times shorter distances of Tyr148
with Thr202 and Thr204 are observed in mdPrP and ePrP
structures compared to wtdPrP (Table S2). A similar trend in
distances was observed between Tyr152 and Thr202. In contrast,
the distances between Tyr152 and Thr204 are similar for all the
three structures. Thr202 and Thr204 are more solvent-exposed in
the ePrP structure with respect to mdPrP and wtdPrP
structures (Figure 7). We observed a closer anchoring of the
α1 helix to α2 and α3 helices in the mdPrP structure with
respect to ePrP and wtdPrP.
Effect of Polymorphism Q226E on Electrostatic
Surface Potential. MdPrP, wtdPrP, and ePrP are known
for their polymorphisms at positions 138 and 226. S138N and
Q226E polymorphisms have a major impact on the electro-
static surface potential of the examined structures (Figure 8).
Our results show that variations in the electrostatic surface
potential among the three proteins are mostly clustered at the
β1−α1 loop, at the beginning of the α2 helix, at the V-shaped
skeleton where the antiparallel β sheet is in proximity to the α2
and α3 helices, and at the C-terminus of the α3 helix (Figure
8).
In contrast to the wtdPrP and ePrP structures, a large
contiguous area of positive electrostatic potential is observed
on the surface of the mdPrP structure. The region around
residue 138 is positively charged in mdPrP, whereas the
corresponding region in wtdPrP and ePrP proteins is neutral.
Additional variations of positive charge in the mdPrP and
wtdPrP structures to a predominantly neutral state in the ePrP
structure are observed in the middle of α2 and α3 helices.
Polymorphism Q226E is reflected in the charge of preferen-
tially positive surface areas in the β2−α2 loop and the C-
terminus of the α3-helix in mdPrP and wtdPrP in comparison
to the negative electrostatic potential in ePrP. However, the C-
terminus of wtdPrP is negatively charged to mdPrP and ePrP.
Residues 225 and 226 are located in a distal region of the α3
helix that participates in interactions with the β2−α2 loop to
form a solvent-accessible contiguous epitope.72 Our data
suggest that different distributions of electrostatic potential
between mdPrP and ePrP proteins may facilitate intra-
molecular interactions between two allelic variants in deer
subspecies in case of S225F and Q226E polymorphisms and
influence the early stages of prion conversion and neuro-
pathology of CWD among cervids.
■ CONCLUSIONS
The spread of CWD in North America and the most recent
cases of CWD-infected cervid subspecies in Europe have raised
concerns for public health and perceived risks for possible
CWD transmission to humans through the consumption of
CWD-infected venison.8,51−53 The possible spontaneous
spread of the disease among cervid subspecies in Eurasia
represents a global threat.54 Structural studies on mdPrP at the
molecular level are important for understanding the still
unknown reasons for the appearance of the detected and
confirmed cases of CWD in captive mule deer3 and the
progressive spread and identification of the disease in other
cervids.
Previous findings suggest that the primary structural
differences at residue 226 identify biologically distinct prion
strains on the basis of different disease progressions in deer and
elk33 and have a role in dictating the selection of different
CWD prion strains in gene-targeted mice.35 These findings
suggest that the observed differences are related to an altered
structure of PrPC caused by the Q226E polymorphism,
highlighting the importance of amino acid sequence variations
affecting the local changes of 3D structures, whereas the
globular fold remains similar. A detailed comparative structural
Table 2. Distances between C Atoms of Selected Amino
Acid Residues in Proximity of the α2−α3 Loop in mdPrP,
wtdPrP, and ePrP Structuresa
markb distance mdPrP (Å) wtdPrP (Å) ePrP (Å)
A Tyr160Cα−Phe201Cζ 6.5 ± 0.3 5.3 5.5 ± 0.4
B Tyr160Cβ−Val187Cβ 11.5 ± 0.4 9.1 8.9 ± 0.3
C Tyr160Cβ−Met209Cβ 5.2 ± 0.1 4.7 5.1 ± 0.3
D Thr194Cγ2−Glu199Cβ 4.8 ± 0.4 5.7 4.2 ± 0.6
E Thr194Cγ2−Asn200Cβ 5.7 ± 0.5 8.3 6.4 ± 1.3
F Glu199Cβ−Phe201Cζ 7.3 ± 0.5 6.8 6.5 ± 0.7
G Asn200Cβ−Phe201Cζ 4.0 ± 0.2 7.5 7.5 ± 0.4
H Ile206Cγ2−Met209Cγ 4.8 ± 0.1 6.5 6.8 ± 0.2
aReported distances are average values obtained from the coordinates
of the structural ensemble for mdPrP (PDB id 6FNV) and ePrP (PDB
id 1XYW) that were determined by NMR and for wtdPrP (PDB id
4YXH) determined by X-ray crystallography. Standard deviations are
reported for the ensemble of 20 lowest energy structures for mdPrP
and ePrP. bLetters specify the position of distances in Figure 5C.
Figure 7. Solvent accessibility of selected residues that belong to the α2 and α3 helices. Hatched and dotted lines at 20 and 50% indicate the limits
of amino acid residue accessibility to solvents (>50%) or burial in solvent-inaccessible regions (<20%). Standard deviations are reported for the
ensemble of 20 lowest energy structures of mdPrP and ePrP that have been determined by NMR.
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analysis of the examined PrP of cervids could provide insights
into pathogenesis suggesting that the structures of deer and elk
prion proteins may determine prion strain mutation in these
cervids.
Our comparative analysis uncovered the structural determi-
nants of mdPrP that are manifested in diverse structural
rearrangements and distinct electrostatic surface potentials
with respect to the wtdPrP and ePrP structures. The region at
the beginning of the C-terminus domain could protect the β-
sheet from solvents, force the closer packing of β1−α1−β2 to
α2−α3 subdomains and raise the structural stability of mdPrP.
These structural features could have a major effect on the prion
conversion. In our previous studies, we have found that amino
acid substitution at position 226 has dramatic effects on CWD
prion replication, pathogenesis, and biochemical properties.73
Tg(DeerPrP) has a longer incubation time compared with
Tg(ElkPrP) mice after inoculation with CWD prions. On the
other hand, Tg(DeerPrP) mice were susceptible to SSBP/1,74
whereas Tg(ElkPrP) mice were completely resistant.71 In
addition, Q226 CWD prions display more resistance to
guanidine denaturation than the E226 CWD prions.35 Our
current findings suggest that the long-range interactions in the
mdPrP protein might stabilize the overall structure, thus
impacting the PrPC-to-PrPSc conversion. The distribution of
electrostatic surface potential on the mdPrP protein may lead
to different intermolecular interactions between PrPC and
PrPSc and in this way may represent a step toward
understanding the underlining mechanism of CWD prion
transmission.
■ METHODS
Plasmid Construction for NMR Sample Preparation.
The recombinant dePrP (94−233) was obtained using the
QuikChange kit (Stratagene) utilizing primers 5′-CAGAGA-
GAATCCCAGGCTTATTACCAAAGA-3 ′ and 5 ′ -
TCTTTGGTAATAAGCCTGGGATTCTCTCTG-3′ and
ePrP(94−234) as templates. The DNA product was then
inserted into pProExHTa (Invitrogen), containing the cleavage
site between the His6 tag and the protein fragment. The cloned
DNA sequences were verified by sequencing.
Prion Protein Expression and Purification. A freshly
transformed overnight culture of E. coli BL21 (DE3) cells
(Stratagene) was added at 37 °C to 2 L of the minimal
medium plus ampicillin (100 mg/mL). For isotope labeling, 4
g/L [13C6] glucose and 1 g/L [
15N] ammonium chloride were
added. At 0.8 OD600, expression was induced with isopropyl β-
D-galactopyranoside to a final concentration of 0.8 mM. Cells
were grown in a Biostat B plus 2 L vessel (Sartorius) and
harvested 18 h after inoculation. The bacterial paste was
resuspended in 25 mM Tris-HCl, 0.8% Triton X-100, and 1
mM phenylmethylsulfonyl f luoride, pH 8.0, and lysed by a Panda
homogenizer. A crude extract was loaded onto a 5 mL HisTrap
column (GE Healthcare) equilibrated in a binding buffer [2 M
GndHCl, 500 mM NaCl, 20 mM Tris-HCl, and 20 mM
imidazole (pH 8.0)] and eluted with 500 mM imidazole. The
purified protein was lyophilized and dissolved in 8 M GndHCl.
The protein was diluted to a final concentration of 0.5 mg/mL
in a tobacco etch virus (TEV) reaction buffer (50 mM Tris
base, 1 mM ethylenediaminetetraacetic acid, and 5 mM
dithiothreitol), and TEV protease was added to the final
concentration of 75 μg/mL. The reaction was incubated at 22
°C overnight. The cleaved sample was loaded onto a 5 mL
HisTrap column (GE Healthcare) equilibrated with a binding
buffer [500 mM NaCl and 20 mM Tris-HCl (pH 8.0)], and
the flow-through containing only the cleaved protein was
collected. The purified protein was lyophilized and redissolved
in 8 M GndHCl. Refolding was performed by dialysis against a
refolding buffer [20 mM sodium acetate and 0.005% NaN3
(pH 5.5)] using a Spectra/Por membrane (molecular weight,
3000). The purified protein was analyzed by sodium dodecyl
sulfate polyacrylamide gel electrophoresis under reducing
conditions, western blot, and electrospray mass spectrometry.
The purification and expression of TEV protease were
obtained as described earlier.75
Figure 8. Electrostatic surface potential of the three cervid PrPs. (A) Ribbon presentation of the mdPrP backbone orientation used in panels (B−
D). Residues Ser138, Ser225, Gln226, Tyr228, and Tyr229 are presented as ball-and-stick and colored black. Electrostatic surface potentials of (B)
mdPrP, (C) wtdPrP, and (D) ePrP. Regions of positive and negative charges are depicted from blue to red according to the presented charge
legend. Orientation of structures is preserved in all panels. The lower set of structures is rotated by 135°.
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NMR Spectroscopy and Structure Calculation. All
NMR experiments used for structure determination were
performed on a 13C, 15N isotopically labeled mdPrP sample on
a Varian VNMRS 800 MHz spectrometer equipped with a
triple 1H/13C/15N resonance cryogenic probe head operating
at 25 K with inverse detection. The sample temperature was
calibrated using the methanol-d3 standard sample to ensure
consistent sample temperature. The sample temperature for all
experiments was 298 K. The sample contained 0.48 mM of
mdPrP in a 20 mM sodium phosphate buffer, pH 5.5. NMR
experiments for NH and HC detection were performed in
90%/10% H2O/D2O and in a 100% deuterated buffer,
respectively. The sequence-specific assignment of the back-
bone 1H, 15N, 13Cα,
13Cβ, and
13CO resonances for mdPrP was
obtained using the 15N-HSQC spectrum and triple-resonance
NMR experiments HNCO, HN(CO)CA, HNCA, CBCA-
(CO)NH, and HNCACB.41 The 1H and 13C resonances of
aliphatic and aromatic side chains were assigned using 13C-
HSQC in combination with HAHB(CO)NH, CC(CO)NH,
(H)CCH-TOCSY, and 13C-edited NOESY-HSQC experi-
ments.42 NOE contacts were determined in 3D 15N and 13C-
edited NOESY-HSQC experiments. Structure modeling of
mdPrP was performed using the program CYANA 3.1.76
Structure refinement using the explicit solvent model was
performed by the YASARA program.77 An ensemble of 20
lowest energy structures of mdPrP was validated by the web
server software ICING44 and PSVS.45
Backbone amide relaxation measurements including 15N
longitudinal (R1), transverse (R2), rotating frame (R1ρ)
relaxation rates, and {1H}−15N heteronuclear NOE were
obtained at two different magnetic fields (14.1 and 18.8 T) at
298 K.78 Residues Gln95, Thr98, Ser100, Asn103, Ser106, Met137,
His143, Tyr165, Asp170, Gln171, Asn174, Asn176, His180, Cys182,
Val187, Met216, and Ile218 could not be analyzed because of the
cross-peak overlap.
All recorded spectra were processed with NMRPipe
software79 and analyzed with CARA80 and SPARKY
software.81 The prediction of backbone dihedral angles was
made by the TALOS+ program.82 Alignment was prepared
using ClustalO.83 An analysis was performed by the web server
GETAREA.49,50 The potentials were calculated at an
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